Jun 24 |
With 45% ownership, MiMedx Group, Inc. (NASDAQ:MDXG) has piqued the interest of institutional investors
|
May 15 |
MIMEDX to Participate in Upcoming Investor Conferences
|
May 2 |
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
|
Apr 16 |
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
|
Mar 27 |
MiMedx slips as FDA reaffirms position on Axiofill
|
Mar 27 |
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
|
Mar 20 |
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
|
Mar 4 |
MIMEDX Announces Appointment of Two New Independent Directors
|
Mar 1 |
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
Mar 1 |
MiMedx Group Full Year 2023 Earnings: EPS Beats Expectations
|